Written by: Mark Wade, Global Practice Leader, TransPerfect Life Sciences
The debate surrounding best practices for patient management and data collection during clinical trials is ongoing.
What is the best process? How do sponsors get the best results? Which method garners the highest quality data while reducing timelines and costs?
In our latest whitepaper “The Tale of Two Trials,” we re-explore the benefits and drawbacks of the traditional, paper-based outcomes assessment method, as well as the advantages of the emerging electronic clinical outcomes assessment (eCOA) solutions. With each having the potential to affect data quality, timelines, and overall trial cost, the choice between them is a much discussed topic.